BeOne Medicines
ONC
#670
Rank
S$50.27 B
Marketcap
S$444.39
Share price
-2.40%
Change (1 day)
7.81%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): S$6.17

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is S$6.15. In 2025 the company made an earnings per share (EPS) of S$3.49 an increase over its 2024 EPS that were of S-$7.98.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$6.1776.77%
2025S$3.49-143.75%
2024S-$7.98
2022S-$24.9428.21%
2021S-$19.45-19.96%
2020S-$24.3020.81%
2019S-$20.1231.52%
2018S-$15.30417.57%
2017S-$2.96-37.16%
2016S-$4.70158.95%
2015S-$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.35-105.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.21-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA